It has been found to slow the progression of kidney disease and reduce the risk of kidney failure in individuals with type 2 diabetes
A comprehensive review of clinical trials involving semaglutide specifically the 2.4 mg dose used for Wegovy highlighted that one of the drugs significant advantages is its effectiveness for long-term weight management
However, those with type 2 diabetes lost a smaller percentage of body weight compared with those without diabetes, researchers reported in the study published in JAMA Network Open
If youre uncomfortable, straining, or dreading the bathroom, your bodys telling you something is off, even if the frequency is technically within range. Keep in mind that a condition called gastroparesis also causes delayed gastric emptying and constipation
Reduced food intake on GLP-1 medications can compromise magnesium intake
Many people eat less while on treatment, which naturally reduces their food intake alongside any alcohol consumption